Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
新辅助纳武利尤单抗联合化疗及同步放化疗（CA209-7AL）后，对不可切除的III期非小细胞肺癌患者进行巩固性纳武利尤单抗治疗与观察的疗效比较：一项随机临床试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02408-3
Qiu, Bo; Zhao, Yuanyuan; He, Wenzhuo; Zeng, Weijin; Zhang, Hongmei; Feng, Weineng; Jia, Jun; Wang, Daodu; Wang, Daquan; Liu, Fangjie; Liu, Songran; Yin, Shaohan; Xie, Chuanmiao; Zhou, Rui; Hu, Yi; Liu, Qianwen; Guo, Jinyu; Guo, Suping; Wu, Yingjia; Luo, Qiaoting; Li, Jibin; Yang, Yunpeng; Xia, Liangping; Zhang, Li; Liu, Hui
